JPWO2023054732A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023054732A5 JPWO2023054732A5 JP2023511553A JP2023511553A JPWO2023054732A5 JP WO2023054732 A5 JPWO2023054732 A5 JP WO2023054732A5 JP 2023511553 A JP2023511553 A JP 2023511553A JP 2023511553 A JP2023511553 A JP 2023511553A JP WO2023054732 A5 JPWO2023054732 A5 JP WO2023054732A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dose
- day
- formula
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 208000001528 Coronaviridae Infections Diseases 0.000 claims 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- 241001678559 COVID-19 virus Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004904 shortening Methods 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023072576A JP2023105826A (ja) | 2022-01-19 | 2023-04-26 | 新型コロナウイルス感染症治療用医薬 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022006725 | 2022-01-19 | ||
| JP2022006725 | 2022-01-19 | ||
| JP2022012386 | 2022-01-28 | ||
| JP2022012386 | 2022-01-28 | ||
| JP2022017132 | 2022-02-07 | ||
| JP2022017132 | 2022-02-07 | ||
| JP2022027629 | 2022-02-25 | ||
| JP2022027629 | 2022-02-25 | ||
| JP2022120325 | 2022-07-28 | ||
| JP2022120325 | 2022-07-28 | ||
| JP2022149666 | 2022-09-21 | ||
| JP2022149666 | 2022-09-21 | ||
| PCT/JP2023/001243 WO2023054732A2 (ja) | 2022-01-19 | 2023-01-18 | 新型コロナウイルス感染症治療用医薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023072576A Division JP2023105826A (ja) | 2022-01-19 | 2023-04-26 | 新型コロナウイルス感染症治療用医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023054732A1 JPWO2023054732A1 (https=) | 2023-04-06 |
| JP7273455B1 JP7273455B1 (ja) | 2023-05-15 |
| JPWO2023054732A5 true JPWO2023054732A5 (https=) | 2023-09-06 |
Family
ID=85780780
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511553A Active JP7273455B1 (ja) | 2022-01-19 | 2023-01-18 | 新型コロナウイルス感染症治療用医薬 |
| JP2023072576A Pending JP2023105826A (ja) | 2022-01-19 | 2023-04-26 | 新型コロナウイルス感染症治療用医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023072576A Pending JP2023105826A (ja) | 2022-01-19 | 2023-04-26 | 新型コロナウイルス感染症治療用医薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250099474A1 (https=) |
| EP (1) | EP4467142A4 (https=) |
| JP (2) | JP7273455B1 (https=) |
| KR (1) | KR20240137021A (https=) |
| AU (1) | AU2023202177A1 (https=) |
| MX (1) | MX2024008910A (https=) |
| WO (1) | WO2023054732A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300412A (en) | 2020-08-24 | 2023-04-01 | Gilead Sciences Inc | Phospholipid compounds and their uses |
| TW202344257A (zh) | 2020-10-16 | 2023-11-16 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| LT4122926T (lt) | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
| WO2024031089A1 (en) | 2022-08-05 | 2024-02-08 | Gilead Sciences, Inc. | Sars-cov2 main protease inhibitors |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999036410A1 (en) * | 1998-01-13 | 1999-07-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| PL2399910T3 (pl) * | 2009-02-13 | 2014-09-30 | Shionogi & Co | Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je |
| CN103153968B (zh) | 2010-08-10 | 2016-02-03 | 盐野义制药株式会社 | 三唑衍生物及含有其的具有镇痛作用的药物组合物 |
| JP6075621B2 (ja) | 2010-08-10 | 2017-02-08 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
| TW201331188A (zh) | 2011-12-15 | 2013-08-01 | Shionogi & Co | 經取代之三□衍生物及含有其之醫藥組成物 |
| WO2013118855A1 (ja) | 2012-02-09 | 2013-08-15 | 塩野義製薬株式会社 | 複素環および炭素環誘導体 |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| WO2019087884A1 (ja) * | 2017-10-31 | 2019-05-09 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| EP4282420A4 (en) * | 2021-01-20 | 2024-11-27 | National University Corporation Hokkaido University | ANTIVIRAL AGENT |
| EP4313097A4 (en) * | 2021-03-29 | 2025-03-19 | Shireen Nature Company for General Trading, Ltd. | Willow extract and its use in treating coronavirus infection, inflammation, and associated medical conditions |
| LT4122926T (lt) * | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
| AU2022353486A1 (en) * | 2021-09-28 | 2024-05-02 | National University Corporation Hokkaido University | Pharmaceutical composition containing triazine derivative |
| EP4289432A4 (en) * | 2021-11-24 | 2025-01-15 | Shionogi & Co., Ltd | PREPARATION FOR ORAL ADMINISTRATION CONTAINING TRIAZINE DERIVATIVES |
-
2023
- 2023-01-18 WO PCT/JP2023/001243 patent/WO2023054732A2/ja not_active Ceased
- 2023-01-18 US US18/729,630 patent/US20250099474A1/en active Pending
- 2023-01-18 AU AU2023202177A patent/AU2023202177A1/en active Pending
- 2023-01-18 MX MX2024008910A patent/MX2024008910A/es unknown
- 2023-01-18 KR KR1020247027109A patent/KR20240137021A/ko active Pending
- 2023-01-18 EP EP23714052.0A patent/EP4467142A4/en active Pending
- 2023-01-18 JP JP2023511553A patent/JP7273455B1/ja active Active
- 2023-04-26 JP JP2023072576A patent/JP2023105826A/ja active Pending